Inviragen Obtains $5,454,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1f8a5288-8e63-4180-bae4-6efe880287cd&Preview=1 - Date
3/31/2012 - Company Name
Inviragen - Mailing Address
1613 Prospect Pkwy. Fort Collins, CO 80525 - Company Description
Inviragen, Inc. is committed to developing safe, effective vaccines to address this need. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide. - Website
http://www.inviragen.com - Transaction Type
Venture Equity - Transaction Amount
$5,454,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Charter Life Sciences Fund - Venture Investor
Venture Investors - Venture Investor
Bio*One Capital Pte
